Trabectedin for the treatment of breast cancer

Maurizio D'Incalci1, Alberto Zambelli2

  • 1a Department of Oncology , IRCCS - Istituto di Ricerche Farmacologiche Mario Negri , Via La Masa 19, Milan 20156 , Italy.

Abstract

Insights

Trabectedin shows potential as an anti-cancer drug for metastatic breast cancer (mBC) by affecting transcription and the tumor microenvironment. Further research is needed to confirm its value in treating mBC.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Trabectedin is an approved anti-tumor agent for soft tissue sarcoma and ovarian cancer.
  • It inhibits cancer cell proliferation by regulating transcription and modulates the tumor microenvironment by reducing tumor-associated macrophages (TAMs).

Purpose of the Study:

  • To review preclinical and clinical data on trabectedin's development in metastatic breast cancer (mBC).

Main Methods:

  • Review of existing preclinical and clinical trial data.
  • Analysis of trabectedin's efficacy and mechanism of action in mBC.

Main Results:

  • Trabectedin exhibits potential activity in mBC, possibly due to its effects on DNA repair and tumor microenvironment modulation.
  • The drug's unique mechanism suggests broader applicability in solid malignancies.

Conclusions:

  • Trabectedin demonstrates potential in mBC, warranting further investigation.
  • Its activity in defective DNA-repair machinery and immune modulation supports its role in cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K